Overview

Evaluation of Next-Day Residual Effects of Tasimelteon Compared With Placebo and Active Control in Healthy Subjects

Status:
COMPLETED
Trial end date:
2018-08-28
Target enrollment:
Participant gender:
Summary
The aim of this study is to investigate next-day residual effects of tasimelteon compared with placebo and active control in healthy subjects.
Phase:
PHASE1
Details
Lead Sponsor:
Vanda Pharmaceuticals
Treatments:
tasimelteon